158 related articles for article (PubMed ID: 2876723)
1. Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.
Kolly M; Pécoud A
Br J Clin Pharmacol; 1986 Oct; 22(4):389-94. PubMed ID: 2876723
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test.
Pécoud A; Zuber P; Kolly M
Int Arch Allergy Appl Immunol; 1987; 82(3-4):541-3. PubMed ID: 2883132
[TBL] [Abstract][Full Text] [Related]
3. Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis.
Schata M; Jorde W; Richarz-Barthauer U
J Allergy Clin Immunol; 1991 Apr; 87(4):873-8. PubMed ID: 1672878
[TBL] [Abstract][Full Text] [Related]
4. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis.
Palma-Carlos AG; Chieira C; Conde TA; Cordeiro JA
Ann Allergy; 1991 Oct; 67(4):394-8. PubMed ID: 1683189
[TBL] [Abstract][Full Text] [Related]
6. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
Janssens MM
Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
[TBL] [Abstract][Full Text] [Related]
7. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
Borum S; Nielsen K; Bisgaard H; Mygind N
Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
[TBL] [Abstract][Full Text] [Related]
8. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
Bachert C; Wagenmann M; Vossen-Holzenkamp S
Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
[TBL] [Abstract][Full Text] [Related]
9. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
Holmberg K; Pipkorn U; Bake B; Blychert LO
Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect.
Bernardini R; Novembre E; Mugnaini L; Rossi ME; Vierucci A
Allergy Asthma Proc; 1998; 19(2):75-80. PubMed ID: 9578915
[TBL] [Abstract][Full Text] [Related]
11. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests.
Rimås M; Kjellman NI; Blychert LO; Björkstén B
Allergy; 1990 Jan; 45(1):18-21. PubMed ID: 1968726
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen.
Hammann C; Kämmerer R; Gerber M; Spertini F
J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1045-50. PubMed ID: 8977503
[TBL] [Abstract][Full Text] [Related]
13. The effect of levocabastine nasal spray in nasal provocation tests.
Palma-Carlos AG; Palma-Carlos ML; Rombaut N
Int J Clin Pharmacol Res; 1988; 8(1):25-30. PubMed ID: 2896636
[TBL] [Abstract][Full Text] [Related]
14. Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens.
Zuber P; Pécoud A
J Allergy Clin Immunol; 1988 Oct; 82(4):590-4. PubMed ID: 2902114
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
Vermeulen J; Mercer M
Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
Hampel FC; Martin BG; Dolen J; Travers S; Karcher K; Holton D
Am J Rhinol; 1999; 13(1):55-62. PubMed ID: 10088031
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx.
Pazdrak K; Górski P; Ruta U
Allergy; 1993 Nov; 48(8):598-601. PubMed ID: 7906926
[TBL] [Abstract][Full Text] [Related]
19. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
Dechant KL; Goa KL
Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
[TBL] [Abstract][Full Text] [Related]
20. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
Frostad AB; Olsen AK
Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]